[Familial focal and segmentary hyalinosis].

Sección de Nefrología, Hospital Alarcos, Avda., Pío XII, s/n. 13002 Ciudad Real.
Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia (Impact Factor: 1.22). 02/2003; 23(2):172-6.
Source: PubMed

ABSTRACT Focal segmental glomerulosclerosis represents a finding in several renal disorders, characterized by proteinuria and sometimes by arterial hypertension and progressive decline in renal function. There are primary (idiopathic and familial) and secundary forms. In the last 20 years several familial cases has been reported, with a great genetic heterogeneity (dominant and recessive forms) and with multiple associations with particular MHC class-I and class-II gene loci, being Al, DR3 o DR7 the most frequently reported. We described three members of same family with focal segmental hyalinosis that shared the HLA haplotype A31 B61 DR13. This association has not been described previously. We highlight that genetic and acquired factors (obesity, hypertension...) could have importance in the development of progressive renal failure in these patients.

Download full-text


Available from: Francisco Rivera, Dec 31, 2014
39 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Primary focal segmental gbomerubosclerosis (FSGS) is a din- icopathobogic entity defined by the presence of proteinuria, commonly nephrotic in range, and by segmental gbomerular scars involving some, but not all, gbomeruli. Described in 1957 by Rich ( I ), FSGS is distinguished clinically from minimal change disease by hematunia: hypertension and renal insuffi- ciency at presentation; significantly poorer response to steroid therapy; and progression to uremia (2). ing of presenting features (clinical on histologic) that may be of prognostic value in defining the ultimate course and response to therapy in patients with this lesion. Almost 40 yr after the original description of this clinicopathologic entity, our knowl- edge of its course and response to therapy is based almost entirely on retrospective analyses! However, based on this experience, we have gained important insights into the thera- peutic response and prognosis of primary FSGS.
    Journal of the American Society of Nephrology 08/1998; 9(7):1333-40. · 9.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We have identified 17 obese patients (body mass index, BMI, 37.9 +/- 4.1) with proteinuria > 1 g/day (1.3-6.4 g/24 h, mean 3.1 +/- 1.7). Their age was 34-70 years (48.3 +/- 10); 11 were females and 6 males. Six patients had only one functioning kidney and a sleep apnea syndrome had been diagnosed in 5. Renal biopsies, obtained in 5 cases, showed focal glomerulosclerosis in 2 cases, minimal changes in 2 and mesangial proliferation in 1. Nine patients (group 1) were treated with hypocaloric diets; body weight significantly decreased (BMI 37.1 +/- 3, 34 +/- 3.5 and 32.6 +/- 3.2 at 0, 6 and 12 months, respectively) as well as proteinuria (2.9 +/- 1.7, 1.2 +/- 1 and 0.4 +/- 0.6 g/24 h). There was a significant correlation between body weight loss and decrease in proteinuria (r = 0.69, p < 0.05). Eight patients (group 2) were treated with captopril, without dietary changes. BMI remained stable but proteinuria showed a dramatic decrease, similar to that in group 1 (3.4 +/- 1.7, 1.2 +/- 0.9 and 0.7 +/- 1 g/24 h, respectively). Renal function remained stable in both groups. In summary, both body weight loss and captopril treatment can induce a sharp decrease in obesity-related proteinuria.
    Nephron 02/1995; 70(1):35-41. DOI:10.1159/000188541 · 13.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The occurrence of focal segmental glomerulosclerosis (FSGS) in a familial pattern has been rarely reported previously. Over the last 10 years we have treated 31 patients among eight families with familial FSGS. The diagnosis was confirmed by renal biopsy in 18 cases, and each family had at least two members in whom the diagnosis was confirmed histologically. Both males and females were affected, as were both blacks and whites. The mean age at presentation was 28 years, with a range of 8 to 56 years. The mean serum creatinine at presentation was 3.7 mg/dL. Twenty-five of the 31 patients progressed to end-stage renal disease; and treatment with prednisone did not appear to retard the progression to end-stage renal disease. Seven patients received a cadaveric renal transplant and none of them showed evidence of recurrence of disease in the graft. The pattern of inheritance in two families appeared to be autosomal dominant; in the other families the pattern of inheritance was less clear and may have been autosomal recessive, although a familial exposure to an unidentified environmental toxin cannot be excluded. Histologic examination of the renal tissue revealed a variety of changes previously described as occurring in FSGS. We conclude that FSGS may occur in a familial pattern that carries a poor prognosis. Further studies of these families may shed light on the pathogenesis of sporadic FSGS.
    American Journal of Kidney Diseases 08/1995; 26(1):34-40. DOI:10.1016/0272-6386(95)90150-7 · 5.90 Impact Factor
Show more